Oxidant stress as a marker for cardiovascular events: Ox marks the spot.
Landmesser
U
U
Harrison
D G
DG
D000109:Acetylcholine; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000494:pharmacology; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D018450:Disease Progression; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D005542:Forearm / Q000098:blood supply; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism; D018384:Oxidative Stress; D011237:Predictive Value of Tests; D012039:Regional Blood Flow / Q000187:drug effects; D016896:Treatment Outcome; D014664:Vasodilation / Q000187:drug effects; D014810:Vitamin E / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D014810:Vitamin E; D009569:Nitric Oxide; D000109:Acetylcholine; D001205:Ascorbic Acid